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A B S T R A C T
Background: Heat shock proteins (HSPs) work as ‘‘chaperones’’ to affect protein folding of newly
synthesized or denatured proteins. HSP 27 plays an important role in coronary artery disease or renal
disease as the result of oxidative stress. Although habitual smoking is well known to induce oxidative
stress, there is no epidemiological evidence between plasma HSP 27 and renal dysfunction or smoking
habits.
Methods: A total of 451 residents (167 men and 284 women, age 65.7 years) underwent a history and
physical examination, and determination of blood chemistries, including plasma levels of HSP 27. HSP
27 levels were measured by using enzyme-linked immunosorbent assay kits.
Results: Elevated HSP 27 levels were independently associated with estimated glomerular ﬁltration rate
(eGFR) (p < 0.001) and smoking habits (p < 0.05). HSP 27 levelswere signiﬁcantly decreased stratiﬁed by
groups of eGFR (p < 0.001 for trend) by analysis of co-variance (ANCOVA) adjusted for age, sex, and
smoking habits. HSP 27 levels were increased with more smoking of cigarettes. In particular, HSP
27 levels were increased in the heavy smokers (20 cigarettes/day) by ANCOVA adjusted for age, sex,
and eGFR compared with non-smokers and light smokers (p < 0.05 for trend).
Conclusions: The present study demonstrated that HSP 27 levels were strongly related to renal
dysfunction and habitual smoking in a dose–response manner in a Japanese general population.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.Introduction
Heat shock proteins (HSPs) can be expressed in coronary artery
disease (CAD) as the result of hypoxia, reperfusion injury, and
oxidative stress [1]. Several HSPs, including HSP 60/65 and HSP 70/
72, have been implicated in atherosclerosis [2,3]. Clinical studies
have been conducted on HSP 27 with increasing attention. It has
been reported that HSP 27 levels are high in patients with cancer
[4–6], chronic obstructive pulmonary disease (COPD) [7,8], and
renal diseases [9,10].
Several human studies [11–13] have shown that plasma HSP
27 levels are elevated in patients with CAD. However, the number* Corresponding author at: Department of Community Medicine, Kurume
University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
Tel.: +81 942 31 7586; fax: +81 942 31 7896.
E-mail address: hadac@med.kurume-u.ac.jp (H. Adachi).
http://dx.doi.org/10.1016/j.jjcc.2015.04.005
0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsof the enrolled subjects was small in some studies [11,12] and
another study was restricted to relatively young subjects with
known CAD [13]. In addition, the studies were conducted
in Western countries where the prevalence of obesity is high
[11–13]. Furthermore, this study aimed to examine the
association between plasma HSP 27 levels and coronary risk
factors in a healthy check-up examination. Accordingly, we
examined factors associated with HSP levels in a relatively large
number (451 subjects) of subjects in a Japanese general
population, where obesity is not commonly observed.
Methods
Study participants
In 2008–2009, in a ﬁshing community in southwestern Japan
(Uku town), a total of 451 people over 40 years of age received a
population-based health examination. This town is an isolatedreserved.
T. Nakayoshi et al. / Journal of Cardiology 67 (2016) 110–114 111island in Sasebo city, located in Nagasaki prefecture, and the total
population is about 3700. A complete dataset of 451 subjects
(167 men and 284 women) on an overnight fast was available in
this study. The detailed backgrounds and characteristics of this
town were described previously [14–16].
Data collection
Height and weight were measured, and body mass index (BMI)
was calculated as weight (kilograms) divided by the square of
height (square meters) as an index of obesity. Blood pressure (BP)
was measured twice with the subjects in the sitting (ﬁrst) and
supine (second) position. Vigorous physical activity and smoking
were avoided for at least 30 min before BP measurement. The
second BP with the ﬁfth phase diastolic pressure was used for
analysis. Blood was drawn from the antecubital vein for
determinations of lipid proﬁles (high-density lipoprotein choles-
terol, low-density lipoprotein cholesterol, and triglycerides),
fasting plasma glucose, insulin, and plasma HSP 27 levels in the
morning after a 12-h fast. Fasting blood samples were centrifuged
within 1 h after collection. Estimated glomerular ﬁltration rate
(eGFR)wascalculatedusing theModiﬁcationofDiet inRenalDisease
study equation modiﬁed with a Japanese coefﬁcient [17]. Plasma
HSP 27 was measured by the human HSP 27 enzyme-linked
immunosorbent assay kits [18]. Intra- and inter-assay coefﬁcient of
variation of HSP 27 at the commercially available laboratory that
performed the assays (The SRL Laboratory, Tokyo, Japan) was 4.6%
and 7.3%, respectively. Other chemistries, such as lipid proﬁles
(enzymatic assay method), glycosylated hemoglobin A1c (NGSP)
(ion-exchange high-performance liquid chromatography) and
creatinine (enzymatic assaymethod), weremeasured at a commer-
ciallyavailable laboratory (Kyodo IgakuLaboratory, Fukuoka, Japan).
Smoking habits
Information about smoking habits was collected using a
standardized questionnaire. Daily cigarette consumption at the
examination was expressed in three categories such as no smoker
(n = 408) including former smoker (n = 85), current smoking of
1–19 (light smoker, n = 18), and 20 or more (heavy smoker, n = 21)Table 1
Demographic and clinical characteristics of study subjects.
Parameters Men (n=167)
Age (year) 66.68.6
Body mass index (kg/m2) 24.02.7
Systolic BP (mmHg) 134.717.0
Diastolic BP (mmHg) 81.710.7
Total cholesterol (mg/l) 193.631.4
HDL-cholesterol (mg/l) 54.813.9
Triglycerides (mg/l)a 94.0 (32–704)
LDL-cholesterol (mg/l) 115.429.7
BUN (mg/l) 18.85.1
Creatinine (mg/l) 0.860.17
eGFR (ml/min/1.73m2) 72.215.6
Uric acid (mg/l) 6.01.3
FPG (mg/l) 104.623.8
Hemoglobin A1c (%) 5.20.6
HSP 27 (mg/l)a 69.1 (8.0–871.0)
Smoking habits (%) 18.7%
Alcohol intake (%) 68.7%
HT medication (%) 58.4%
DL medication (%) 29.3%
DM medication (%) 8.6%
History of CHD (%) 9.2%
Data are means standard deviation or percentage, unless otherwise indicated.
BP, blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; BUN, blo
rate; HSP, heat shock protein; HT, hypertensive; DL, dyslipidemic; DM, diabetes mellitu
a Log-transformed values were used for the calculation and reconverted to anti-logacigarettes per day. We evaluated the Brinkmann index in each
smoker group. Brinkman index values were calculated as the
number of cigarettes smoked per day multiplied by the number of
years of smoking.
The mayor and the welfare section of Uku town approved this
study. The ethical committee of Kurume University also approved
this study. All participants gave informed consent.
Statistical analysis
Because of skewed distributions, the natural logarithmic (ln)
transformations were performed for triglycerides and HSP 27. Log-
transformed values were reconverted to antilogarithm forms in
tables and ﬁgures. Medications for hypertension, hyperlipidemia,
and diabetes were coded as dummy variables. Alcohol intake and
history of coronary heart disease (CHD)were also coded as dummy
variables. Univariate analysis for HSP 27 was performed by a linear
regression analysis. Multiple stepwise regression analysis was
performed for independent associated factors of HSP 27. Mean HSP
27 levels stratiﬁed by the three categories of eGFR levels were
compared using analysis of co-variance (ANCOVA) adjusted for
age, sex, and smoking habits. Mean HSP 27 levels stratiﬁed by the
three categories of smoking habits were compared using ANCOVA
adjusted for age, sex, and eGFR. Statistical signiﬁcance was deﬁned
as p < 0.05. All statistical analyses were performed using SAS
version 9.3 (SAS Inc., Cary, NC, USA).
Results
Demographic and clinical characteristics of study subjects are
presented in Table 1. Mean values of plasma HSP 27 levels were
69.1mg/l inmen and 54.2 mg/l in women, respectively. Most of the
subjects were non-obese. The prevalence of alcohol intake and
smoking habit in males were signiﬁcantly higher than in females.
Table 2 shows univariate analyses with plasma HSP 27 as a
dependent variable. Systolic (p < 0.05) and diastolic (p < 0.05) BPs,
smoking habits (p < 0.05), eGFR (p < 0.01), uric acid (p < 0.001),
and a history of CHD (p < 0.01) were signiﬁcantly associated with
HSP 27 levels. For the signiﬁcant factors shown in Table 2, we
performed multiple stepwise regression analysis (Table 3). PlasmaWomen (n=284) Total (n=451)
65.19.9 65.79.4
23.73.4 23.83.2
136.217.8 135.717.5
79.49.7 80.310.1
206.833.9 201.933.6
61.914.0 59.314.4
80.9 (33–371) 85.5 (32–704)
125.932.0 122.031.5
17.44.9 17.95.0
0.670.14 0.74 0.18
71.116.3 71.516.0
4.91.2 5.31.3
91.911.1 96.618.0
5.10.5 5.2 0.6
54.2 (0.1–1273.9) 58.8 (0.1–1273.9)
2.9% 8.7%
19.9% 38.0%
50.0% 53.1%
38.2% 34.9%
2.0% 4.5%
8.2% 8.6%
od urea nitrogen; FPG, fasting plasma glucose; eGFR, estimated glomerular ﬁltration
s; CHD, coronary heart disease.
rithm forms.
Table 2
Univariable analysis for correlates of logHSP 27 levels.
Characteristics b SE p
Age (years) 0.005 0.004 0.220
Sex 0.170 0.090 0.060
BMI (kg/m2) 0.002 0.017 0.911
Systolic BP (mmHg) 0.007 0.003 0.047
Diastolic BP (mmHg) 0.013 0.005 0.012
Total cholesterol (mg/dl) 0.001 0.002 0.701
HDL-cholesterol (mg/dl) 0.001 0.004 0.980
Triglycerides (mg/dl)a 0.137 0.110 0.213
LDL-cholesterol (mg/dl) 0.001 0.002 0.749
BUN (mg/dl) 0.003 0.008 0.750
Creatinine (mg/dl) 0.820 0.230 <0.001
eGFR (ml/min/1.73m2) 0.008 0.003 0.004
Uric acid (mg/dl) 0.129 0.039 <0.001
FPG (mg/dl) 0.002 0.003 0.427
Hemoglobin A1c (%) 0.046 0.024 0.058
Smoking habits (%) 0.405 0.184 0.029
Alcohol intake (%) 0.063 0.111 0.569
HT medication (%) 0.141 0.106 0.183
DL medication (%) 0.005 0.110 0.961
DM medication (%) 0.268 0.213 0.210
History of CHD (%) 0.220 0.070 0.003
BP, blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein;
BUN, blood urea nitrogen; FPG, fasting plasma glucose; eGFR, estimated
glomerular ﬁltration rate; HSP, heat shock protein; HT, hypertensive; DL,
dyslipidemic; DM, diabetes mellitus; CHD, coronary heart disease.
b indicates standardized regression coefﬁcients: men=0, women=1.
[1_TD$DIFF]Bold values are signiﬁcant at p<0.05.
a Log-transformed values were used for the analysis.
Table 3
Multiple stepwise regression analysis for correlates of logHSP 27 levels.
Characteristics b SE p
eGFR 0.009 0.003 <0.001
Smoking habits 0.442 0.191 0.021
R2 =0.047.
eGFR, estimated glomerular ﬁltration rate.
[2_TD$DIFF]Bold values are signiﬁcant at p<0.05.
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Fig. 2. Age, sex, and estimated glomerular ﬁltration adjusted means of heat shock
protein (HSP) 27 levels stratiﬁed by the three groups of smoking habits were
compared using analysis of co-variance.
T. Nakayoshi et al. / Journal of Cardiology 67 (2016) 110–114112HSP 27 levels were signiﬁcantly and independently associated
with eGFR (inversely; p < 0.001) and smoking habit (p < 0.05). Age,
sex, andsmokinghabits adjustedmeansofHSP27 levels stratiﬁedby
the three groups of eGFR were compared using ANCOVA, which
indicated the inverse signiﬁcant trend (p < 0.001) (Fig. 1). Age, sex,
and eGFR adjusted means of HSP 27 levels stratiﬁed by the three
groups of smoking habits were compared using ANCOVA, which
demonstrated a signiﬁcant trend (p< 0.05) (Fig. 2).
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Fig. 1. Age, sex, and smoking habits adjusted means of heat shock protein (HSP)
27 levels stratiﬁed by the three groups of estimated glomerular ﬁltration rate
(eGFR) were compared using analysis of co-variance.Discussion
Our study demonstrated that renal dysfunction and smoking
habit were the independent associated factors for plasma HSP
27 levels. To the best of our knowledge, this is the ﬁrst report to
demonstrate a signiﬁcant association between HSP 27 and renal
dysfunction or smoking habit in an epidemiological study.
Although medications for hypertension, dyslipidemia, and
diabetes were not correlated with circulating HSP 27 levels in
our analyses, we were not able to exclude the contributions of
some therapeutic agents.
Plasma HSP 27 levels and renal dysfunction
It has not been well known that HSP levels were inversely
associated with eGFR, possibly because several studies were
conducted in a small number of subjects, only children on chronic
dialysis ormice with obstructive nephropathy [9,10]. In contrast to
these previous studies, we includedmany healthy subjects, inwide
ranges of age from 40 to 85 years in this study. Musiał and
colleagues [9] showed the positive relationship between HSP
27 concentrations and renal dysfunction in children with chronic
kidney disease. However, details of the mechanisms and patho-
physiology remain scant in the relationship with renal dysfunc-
tion. In order to examine the inﬂuence of renal dysfunction,
Vidyasagar and colleagues [10] measured HSP levels in transgenic
mice. They found that HSP 27 up-regulation was associated with
reduced ﬁbrinogen after unilateral ureteral obstruction [10], which
suggested that tubular HSP 27 inhibits ﬁbrogenesis in obstructive
nephropathy [10].
It is interesting to note that eGFR levels of our participants were
in normal ranges of 72.2  15.6 ml/min/1.73 m2 in men and
71.1  16.3 ml/min/1.73 m2 in women, respectively. Nevertheless,
an inverse and signiﬁcant trend (p < 0.001) in Fig. 1 was striking and
may deserve further investigation.
Plasma HSP 27 levels and smoking habits
As consistent with other previous studies [1,2,11–13], we
demonstrated the positive association of plasma HSP 27 and
coronary risk factors, including systolic and diastolic BPs, smoking
habits, and history of CHD in univariate analysis (Table 2). It must
be borne in mind that many of these previous studies [11,13] were
done inwestern countrieswith high BMI levels (26–27.0 kg/m2). In
Asia, a Korean group reported the positive relationship between
T. Nakayoshi et al. / Journal of Cardiology 67 (2016) 110–114 113HSP 27 and acute coronary syndrome in a small number of the
enrolled subjects [1], and a few Japanese investigators [19,20]
reported that plasma HSP 27 plays an important role as a
prognostic factor in cancers. However, there have been no studies
to demonstrate the association between HSP 27 and coronary risk
factors in a general population.
Recently, smoking among Asian men has been more common
than in the United Kingdom and USA, and opposite in women
[21]. Smoking rates in men were 18.7% and those in women were
2.9% in the present study. In this background, our data indicated
that plasma levels of HSP 27 were strongly related to smoking
status in a dose–response manner. Only one investigation from
Europe showed that serum levels of HSP 27 correlated with early
radiological signs of COPD in 120 apparent healthy smokers [8],
which is consistent with the present study. Although the
mechanisms are not still clear, oxidative stress may play an
important role betweenHSP 27 and cigarette smoking [22,23]. Fur-
ther, the present study indicated a clear dose–response relation-
ship between HSP 27 and smoking status, in which HSP 27 might
be increased as a marker of smoking-speciﬁc oxidative stress
[24]. Although former smokers were included in the no smoker
group in this study, former smokers showed an almost normal
range of HSP 27 levels. The fact that a favorable effect of smoking
cessation on oxidative stress is consistent with the previous
studies [25–27].
Study limitations and clinical perspectives
There are several limitations to our study. First, the study design
was cross-sectional. Thus, nothing conclusive for the association of
HSP 27 with renal dysfunction and smoking habits can be stated, if
the elevation of HSP 27 levels is the cause or the result. Prospective
studies are needed to investigate the role of HSP 27 in smokers,
especially in the aspects of mortality or cardiovascular events.
Second, from the multiple correlation coefﬁcients, these two
factors explained only 4.7% of the variation of HSP 27. Third,
althoughmedications for hypertension, dyslipidemia, and diabetes
were not correlated with circulating HSP 27 levels in our analyses,
we were not able to exclude the contributions of some therapeutic
agents. Fourth, we do not have the data on passive smoking in the
no smoker group. Also, we do not have the data regarding time
interval from ﬁnal smoking to blood sampling. Finally, uric acid
was strongly associated with HSP 27 in univariate analysis, for
which mechanisms should be clariﬁed in future studies.
Because HSP 27 is increased after several stresses such as
hypoxia, reperfusion, and oxidative stress, the increased plasma
levels of HSP 27 may represent chronic inﬂammation or
endothelial damage, suggesting that HSP 27 can be a novel
biomarker in atherosclerosis progression.
Conclusions
In conclusion, the present study demonstrated that plasma HSP
27 levels were strongly associated with renal dysfunction and
smoking habits in community-dwelling Japanese. Plasma HSP
27 may play a role in atherosclerotic diseases.
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